However, the role of gastrin or PPI in the progression to EAC is controversial because some studies [225,228,229,230], but not others [225,231] report that long-term PPI treatment may decrease BE progression and be beneficial in BE patients. This evidence concerns the gene GAST and Barrett esophagus.